Skip to main content
Log in

VP gel cost saving and reduces preterm birth

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. funded by Watson Pharmaceutics (now Actavis)

Reference

  • Pizzi LT, et al. Cost and Cost Effectiveness of Vaginal Progesterone Gel in Reducing Preterm Birth: An Economic Analysis of the PREGNANT Trial. PharmacoEconomics : 9 Apr 2014. Available from: URL: http://dx.doi.org/10.1007/s40273-014-0133-2

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

VP gel cost saving and reduces preterm birth. PharmacoEcon Outcomes News 701, 7 (2014). https://doi.org/10.1007/s40274-014-1204-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1204-5

Navigation